“Structure-Based Design and Computational Validation of Novel 1,3,4-Thiadiazole-Peptide Conjugates as Selective Cyclin-Dependent Kinase-2 (CDK2) Inhibitors for Lung Cancer Therapy” (2026) Pakistan Journal of Medical & Cardiological Review, 5(2), pp. 1174–1180. doi:10.66021/pakmcr903.